United States · 
Who invested in Regenacy Pharmaceuticals?
Regenacy Pharmaceuticals's investors include Taiwania Capital and 3E Bioventures.
United States · Series B startup
Who invested in Regenacy Pharmaceuticals
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Regenacy Pharmaceuticals and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$9.3Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $9.3MAug 2022
- Investors
- 2
The rounds
- Aug 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Regenacy Pharmaceuticals
How much has Regenacy Pharmaceuticals raised?
Regenacy Pharmaceuticals has raised $9.3M across 1 round since 2022.
When did Regenacy Pharmaceuticals last raise?
Regenacy Pharmaceuticals's most recent round was a Series B of $9.3M in Aug 2022.
What was Regenacy Pharmaceuticals's biggest round?
Its most recent round, $9.3M in Aug 2022, is also its largest on record.
Who backed Regenacy Pharmaceuticals first?
Regenacy Pharmaceuticals's first round on record, in Aug 2022, was backed by Taiwania Capital and 3E Bioventures.
What stage is Regenacy Pharmaceuticals at?
Regenacy Pharmaceuticals's latest named round is a Series B, in Aug 2022.
Where is Regenacy Pharmaceuticals based?
Regenacy Pharmaceuticals is based in the United States.
Companies like Regenacy Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.